Final height in children with steroid‐sensitive nephrotic syndrome

Background: Growth retardation following steroid treatment in children is a major problem. Reduction of steroid dose has been tried using immunosuppressive agents such as cyclosporine A or mizoribine in children with frequently relapsing nephrotic syndrome. Few reports concerning final height in steroid‐sensitive nephrotic syndrome (SSNS) are available.

[1]  M. Kemper,et al.  Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. , 2005, The Journal of pediatrics.

[2]  G. Rizzoni,et al.  Long-term linear growth of children with severe steroid-responsive nephrotic syndrome , 2003, Pediatric Nephrology.

[3]  T. Miyawaki,et al.  Influence of Prolonged Corticosteroid Therapy on the Outcome of Steroid-Responsive Nephrotic Syndrome , 2001, American Journal of Nephrology.

[4]  J. Ingelfinger,et al.  Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). , 2000, Pediatrics.

[5]  K. Sawai,et al.  Convulsion during cyclosporin A therapy for nephrotic syndrome , 2000, Clinical and Experimental Nephrology.

[6]  M. Kitamura.  [Growth retardation in children with frequent relapsing nephrotic syndrome on steroid--improvement of height velocity after administration of immunosuppressive agent]. , 1992, Nihon Jinzo Gakkai shi.

[7]  K. Tachibana,et al.  Longitudinal Standards for Height and Height Velocity for Japanese Children from Birth to Maturity , 1992 .

[8]  Y. Kim,et al.  Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome. , 1988, Clinical nephrology.

[9]  S. R. Meadow,et al.  HEIGHT ATTAINMENT IN CHILDREN WITH STEROID-RESPONSIVE NEPHROTIC SYNDROME , 1985, The Lancet.